Green Planet Bioengineering Co., Ltd. reported its financial results for the six months ending June 30, 2026, revealing a net loss of $16,849, compared to a loss of $10,945 for the same period in 2025. The company’s administrative expenses increased to $16,849 from $10,945 year-over-year, reflecting a rise in operational costs. The company has not generated any revenue during this period, maintaining its status as a public reorganized shell corporation with no active business operations.

The financial position of Green Planet Bioengineering shows a working capital deficit of $517,825 as of June 30, 2026, compared to a deficit of $500,976 at the end of 2025. The total liabilities increased slightly to $517,825 from $500,976, primarily due to an increase in amounts due to a related party, which rose to $513,975 from $484,678. The company continues to rely on financial support from a related party, which is crucial for covering its operational expenses.

In terms of operational metrics, the company has not reported any significant changes in customer counts or user statistics, as it has no active business operations. The total number of shares outstanding remains at 20,006,402, with no new shares issued during the reporting period. The company’s employee headcount has not been disclosed, but it is implied that the operational scale remains minimal given the lack of business activity.

Looking ahead, Green Planet Bioengineering's management indicated that the company will continue to seek adequate funding from future investors to pursue potential business opportunities. However, the ability to execute its business plans is contingent upon identifying profitable opportunities and securing necessary financing. The company’s financial statements express substantial doubt about its ability to continue as a going concern, emphasizing the reliance on support from its majority stockholder and related parties.

Overall, Green Planet Bioengineering's financial results reflect ongoing challenges as it navigates its status as a shell corporation. The lack of revenue generation and reliance on external funding sources underscore the uncertainties facing the company as it seeks to establish a viable business operation in the future.

About Green Planet Bio Engineering Co. Ltd.

Green Planet Bioengineering Co., Ltd. is a shell company focused on acquiring or merging with existing businesses. Historically involved in agritech in China, it operates as a public reorganized shell with no current operations. Its primary value lies in its potential to facilitate future acquisitions, relying on external funding and business opportunities, with a focus on compliance and financial transparency.

This description was generated via AI from an annual report. Updated about 1 year ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.

View the complete official filing on the SEC website.

Read on SEC.gov